标题
Drug combination therapy for emerging viral diseases
作者
关键词
Emerging viral diseases, SARS-CoV-2, COVID-19, Drug combination therapy
出版物
DRUG DISCOVERY TODAY
Volume 26, Issue 10, Pages 2367-2376
出版商
Elsevier BV
发表日期
2021-05-22
DOI
10.1016/j.drudis.2021.05.008
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801
- (2021) Angela Wahl et al. NATURE
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens
- (2020) Gregory D. Huhn et al. PLoS One
- Charting the Fragmented Landscape of Drug Synergy
- (2020) Christian T. Meyer et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study
- (2020) Susan E. Sloan et al. ANTIVIRAL RESEARCH
- High success rates for the use of sofosbuvir/ombitasvir/paritaprevir/ritonavir + ribavirin and sofosbuvir/simeprevir/daclatasvir + ribavirin in retreatment of chronic hepatitis C infection after unsuccessful sofosbuvir/daclatasvir therapy: a real-life experience
- (2020) Ebada Mohamed Said et al. ARCHIVES OF VIROLOGY
- Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2
- (2020) Ren-Di Jiang et al. CELL
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
- (2020) Linlin Bao et al. NATURE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-world adherence and persistence for newly-prescribed HIV treatment: single versus multiple tablet regimen comparison among US medicaid beneficiaries
- (2020) Joshua Cohen et al. AIDS Research and Therapy
- Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
- (2020) Yadi Zhou et al. Cell Discovery
- Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks
- (2020) Denise J. Wooding et al. CLINICAL MICROBIOLOGY AND INFECTION
- Middle East Respiratory Syndrome (MERS) Coronavirus
- (2020) R.B. McFee DM DISEASE-A-MONTH
- Drug discovery strategies for SARS-CoV-2
- (2020) Zeenat A Shyr et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Opportunities for Small Molecules in Cancer Immunotherapy
- (2020) Sabina Y. van der Zanden et al. TRENDS IN IMMUNOLOGY
- Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment
- (2020) Victoria C. Yan et al. ACS Medicinal Chemistry Letters
- Managing HIV‐associated inflammation and ageing in the era of modern ART
- (2020) M Bloch et al. HIV MEDICINE
- Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19
- (2020) Bruno M. Tomazini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Animal models for COVID-19
- (2020) César Muñoz-Fontela et al. NATURE
- SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
- (2020) Emma S. Winkler et al. NATURE IMMUNOLOGY
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
- (2020) Evan J. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review
- (2020) Kawthar Mohamed et al. BIOORGANIC CHEMISTRY
- Synergistic and Antagonistic Drug Combinations against SARS-CoV-2
- (2020) Tesia Bobrowski et al. MOLECULAR THERAPY
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Cytokine Storm
- (2020) David C. Fajgenbaum et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets
- (2020) Robert M. Cox et al. Nature Microbiology
- Immune system control of hepatitis C virus infection
- (2020) Johnasha D Stuart et al. Current Opinion in Virology
- Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study
- (2019) Ellie Hershberger et al. EBioMedicine
- Predicting Synergism of Cancer Drug Combinations Using NCI-ALMANAC Data
- (2019) Pavel Sidorov et al. Frontiers in Chemistry
- Applying synergy metrics to combination screening data: agreements, disagreements and pitfalls
- (2019) Anna H.C. Vlot et al. DRUG DISCOVERY TODAY
- Comparative Effectiveness of Combined Favipiravir and Oseltamivir Therapy Versus Oseltamivir Monotherapy in Critically Ill Patients With Influenza Virus Infection
- (2019) Yeming Wang et al. JOURNAL OF INFECTIOUS DISEASES
- Monoclonal Antibody Therapy for Ebola Virus Disease
- (2019) Myron M. Levine NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
- (2019) Sabue Mulangu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures
- (2018) Julie Dyall et al. JOURNAL OF INFECTIOUS DISEASES
- Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro
- (2018) Jin Shin et al. Viruses-Basel
- Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry
- (2018) Shu Yang et al. Cell Discovery
- Evaluation of MEDI8852, an Anti-Influenza A Monoclonal Antibody, in Treating Acute Uncomplicated Influenza
- (2018) S. Omar Ali et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Advancing precision medicine with personalized drug screening
- (2018) Kirill Gorshkov et al. DRUG DISCOVERY TODAY
- No impact of resistance-associated substitutions on the efficacy of sofosbuvir, velpatasvir, and voxilaprevir for 12 weeks in HCV DAA-experienced patients
- (2018) Christoph Sarrazin et al. JOURNAL OF HEPATOLOGY
- Investigating Different Mechanisms of Action in Combination Therapy for Influenza
- (2018) Kelli Melville et al. Frontiers in Pharmacology
- History and Emergence of Zika Virus
- (2017) Duane J Gubler et al. JOURNAL OF INFECTIOUS DISEASES
- Probes & Drugs portal: an interactive, open data resource for chemical biology
- (2017) Ctibor Skuta et al. NATURE METHODS
- Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
- (2017) Marc Bourlière et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug resistance in influenza A virus: the epidemiology and management
- (2017) Mazhar Hussain et al. Infection and Drug Resistance
- Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
- (2016) Travis K. Warren et al. NATURE
- Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen
- (2016) Miao Xu et al. NATURE MEDICINE
- Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy
- (2016) S. Scott Sutton et al. PHARMACOTHERAPY
- Current status and prospects of HIV treatment
- (2016) Tomas Cihlar et al. Current Opinion in Virology
- Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study
- (2015) Anita Kohli et al. LANCET
- Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada
- (2013) Hasina Samji et al. PLoS One
- Understanding synergy
- (2012) Nori Geary AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Combination Antiviral Therapy for Influenza: Predictions From Modeling of Human Infections
- (2012) Alan S. Perelson et al. JOURNAL OF INFECTIOUS DISEASES
- Systematic identification of synergistic drug pairs targeting HIV
- (2012) Xu Tan et al. NATURE BIOTECHNOLOGY
- Combination Nucleoside/Nucleotide Reverse Transcriptase Inhibitors for Treatment of HIV Infection
- (2011) Maxwell O Akanbi et al. EXPERT OPINION ON PHARMACOTHERAPY
- Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro
- (2010) Jack T. Nguyen et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now